AbbVie | ABBV - Vermögenswerte





Vermögenswerte Veränderung Datum
AbbVie USD 147.68B 12.57B 2026-09
Abbott USD 108.25B 968M 2026-09
ALKERMES USD 4.44B 42.4M 2026-09
Amgen USD 96.05B 409M 2026-09
AstraZeneca USD 119.92B 4.09B 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Coherus Biosciences USD 191.18M 74.84M 2026-06
Eisai JPY 1.56T 108.98B 2026-06
Eli Lilly USD 148.07B 5.79B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merck USD 132.77B 2.97B 2026-09
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Pacira USD 34.68B 33.44B 2026-09
Perrigo USD 7.48B 124.6M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
UCB EUR 18.16B 971M 2025-12
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
United Therapeutics USD 7.03B 186M 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09
Zoetis USD 15.09B 11M 2026-09